Risk on Risk Off
-
What to expect next week?
Currencies and stocks extended their sell-off on Friday as risk aversion intensified in financial markets. The Dow Jones Industrial Average exceeds 400 points for ... -
Drought spreads to major agricultural states in the United States
The mainland is visible, in a section that is normally underwater, on the shores of Lake Oroville, which is California’s second largest reservoir and, ... -
Massive dollar and dowmark breakouts, but are there any post-FOMC trends?
Dollar, Dow Jones, USDCAD, EURUSD and GBPUSD talking points: The FOMC announced at the end of its two-day meeting that its members had brought ... -
Facebook, Inc. (NASDAQ: FB), Google Inc. (NASDAQ: GOOG) – EU Supreme Court Says Facebook and Other Big Tech Also Subject to EU Privacy Rules: Report
The EU Court of Justice clarified that large tech companies would be subject to investigations by national data watchdogs regardless of the company’s home ... -
California’s riparian forests are at risk of decline – Courthouse News Service
The state’s vital forest ecosystems have become dependent on water supplied by humans and may no longer be able to survive when the tap ... -
Mel de Charmed takes a risk that changes her life
In the last episode of Charmed, Mel decides to be of service to his future self who will change his life and that of ... -
We believe Daimler (ETR: DAI) is taking risks with its debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett said “volatility is far ... -
Sponsors Withdraw From Copa America In Brazil Due To Covid Risk
A trio of corporate sponsors – Mastercard, Ambev and Diageo – have withdrawn their marks from the Copa America football competition in Brazil, which ... -
Aptose Biosciences (NASDAQ: APTO) – Aptose Biosciences share drops as luxeptinib fails to impress at EHA2021 virtual conference
Aptose Biosciences Inc (NASDAQ: APTO) highlighted data from its luxeptinib currently in two Phase 1 a / b trials – one in relapsed or ... -
(TYME) – Tyme stock trades higher on pipeline update after strategic review, fourth quarter results
Tyme Technologies Inc (NASDAQ: TYME) announced a breast cancer trial with Georgetown University named OASIS. Registration is expected to begin in the third quarter ...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/2INCXG24KNPJVHEPKCCPAEM7QI.jpg)
